A vaccine with the potential to be the world’s first preventive Breast Cancer vaccine is waiting for funding to start clinical trials on women.
The vaccine has been proven to prevent Breast Cancer in three different mice models, but has not yet been tested on women. Documented research has shown that what has worked on mice has also worked on women.
The doctor who developed the vaccination and a Memorial Sloan-Kettering cancer surgeon, Dr. Kathleen T. Ruddy, are now working to find funding to start the trials. The vaccine would be given to women after their child-bearing years, or to high-risk patients. Dr. Kathleen Ruddy says that if it works in women, it could be a game changer for cancer treatment.
“For women who have stage four breast however, the women who are going to die of this disease their survival has not moved at all in thirty or forty years,” Dr. Ruddy says, “there's good evidence that points in the direction that a large portion, perhaps the majority is caused by a virus or several viruses and we must be able to intercept the ongoing process of disease formation by finding ways to prevent it entirely.”
In a special Medical Moment tomorrow before 6 pm find out more about this exciting research, which U.S. organizations turned down funding requests, and how the Chinese are among those in negotiations to front the money for the first clinical trials.